| Asra Ghori, SLP | |
|
16120 Ne 8th St, Bellevue, WA 98008-3937 | |
| (425) 653-4308 | |
| Not Available |
| Full Name | Asra Ghori |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 16120 Ne 8th St, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184740219 | NPI | - | NPPES |
| 7018120 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL00004345 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Asra Ghori, SLP 16120 Ne 8th St, Bellevue, WA 98008-3937 Ph: (425) 653-4308 | Asra Ghori, SLP 16120 Ne 8th St, Bellevue, WA 98008-3937 Ph: (425) 653-4308 |
News Archive
BASF today announced that the Environmental Protection Agency (EPA) has approved the use of Aseptrol® S10 - Tab in H1N1 sanitization operations in institutional and industrial facilities, such as, schools, hospitals, government buildings, retail and restaurants, and recreational facilities. Aseptrol S10 - Tab is based on Chlorine dioxide (CIO2) release technology.
"At the forefront of the fight against child mortality and morbidity, India is leading the global community in placing a renewed emphasis on this important mission," William Hammink, India mission director, writes in USAID's "IMPACTblog," adding the country's "Call to Action for Child Survival and Development" summit, taking place this week, "demonstrates leadership and commitment to both the global community and the children of India."
"Relatives of two woman who died in childbirth launched a landmark lawsuit against the Ugandan government Friday to highlight the failure to provide adequate maternal healthcare," Sapa/Agence France-Presse/IOL reports.
Spectrum Pharmaceuticals, a commercial-stage biotechnology company with a primary focus in oncology, today announced that it has entered into a co-development and commercialization agreement with TopoTarget A/S for Belinostat, a novel histone deacetylase (HDAC) inhibitor.
› Verified 6 days ago
Alexandra Marie Gomez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1417 116th Ave Ne, Suite 110, Bellevue, WA 98004 Phone: 425-688-5900 Fax: 425-688-5912 | |
Elise Morrison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 Fax: 425-502-8425 | |
Andrea Nicole Jamieson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Mrs. Katherine Jeanne Oberhofer, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1417 116th Ave Ne Ste 110, Bellevue, WA 98004 Phone: 425-688-5911 Fax: 425-688-5912 | |
Mrs. Lori Anne Price, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Lummi Key, Bellevue, WA 98006 Phone: 425-643-2919 Fax: 425-657-0691 | |
Mackenzie Bush, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13333 Ne Bel Red Rd Ste 100, Bellevue, WA 98005 Phone: 501-352-0101 | |
Genenvieve Decantis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 |